Isabelle Castan-Laurell
Overview
Explore the profile of Isabelle Castan-Laurell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
1224
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saint-Laurent C, Mazeyrie L, Tajan M, Paccoud R, Castan-Laurell I, Valet P, et al.
Biomedicines
. 2022 Sep;
10(9).
PMID: 36140242
The SH2 containing protein tyrosine phosphatase 2(SHP2) plays essential roles in fundamental signaling pathways, conferring on it versatile physiological functions during development and in homeostasis maintenance, and leading to major...
2.
Personnaz J, Piccolo E, Dortignac A, Iacovoni J, Mariette J, Rocher V, et al.
Sci Adv
. 2022 Mar;
8(12):eabg9055.
PMID: 35333579
Dysregulations of lipid metabolism in the liver may trigger steatosis progression, leading to potentially severe clinical consequences such as nonalcoholic fatty liver diseases (NAFLDs). Molecular mechanisms underlying liver lipogenesis are...
3.
Castan-Laurell I, El Boustany R, Pereira O, Potier L, Marre M, Fumeron F, et al.
Diabetes Care
. 2019 Dec;
43(2):e15-e16.
PMID: 31806652
No abstract available.
4.
Castan-Laurell I, Masri B, Valet P
Expert Opin Ther Targets
. 2018 Dec;
23(3):215-225.
PMID: 30570369
Apelin, a bioactive peptide, is the endogenous ligand of APJ, a G protein-coupled receptor which is widely expressed in peripheral tissues and in the central nervous system. The apelin/APJ system...
5.
Bertrand C, Pradere J, Geoffre N, Deleruyelle S, Masri B, Personnaz J, et al.
Endocrine
. 2018 Feb;
60(1):112-121.
PMID: 29392617
Purpose: Apelin treatment has been shown to improve insulin sensitivity in insulin resistant mice by acting in skeletal muscles. However, the effects of systemic apelin on the hepatic energy metabolism...
6.
Gourdy P, Cazals L, Thalamas C, Sommet A, Calvas F, Galitzky M, et al.
Diabetes Obes Metab
. 2017 Jul;
20(1):157-164.
PMID: 28681996
Aims: Apelin is a recently identified adipokine known to improve glucose tolerance and insulin sensitivity in murine models. This study was dedicated to the proof of concept that apelin administration...
7.
Bertrand C, Valet P, Castan-Laurell I
Front Physiol
. 2015 Apr;
6:115.
PMID: 25914650
A wide range of adipokines identified over the past years has allowed considering the white adipose tissue as a secretory organ closely integrated into overall physiological and metabolic control. Apelin,...
8.
Masri B, Dray C, Knauf C, Valet P, Castan-Laurell I
Med Sci (Paris)
. 2015 Apr;
31(3):275-81.
PMID: 25855281
The APJ receptor cloned in 1993 found its ligand in 1998 with the discovery of apelin. The presence of APJ in the central nervous system (more particularly in the hypothalamus)...
9.
Bertrand C, Pignalosa A, Wanecq E, Rancoule C, Batut A, Deleruyelle S, et al.
PLoS One
. 2013 Nov;
8(11):e78874.
PMID: 24244380
Various studies have shown that eicosapentaenoic acid (EPA) has beneficial effects on obesity and associated disorders. Apelin, the ligand of APJ receptor also exerts insulin-sensitizing effects especially by improving muscle...
10.
Olivier I, Theodorou V, Valet P, Castan-Laurell I, Ferrier L, Eutamene H
Life Sci
. 2013 Nov;
94(1):1-7.
PMID: 24215755
Aims: Adipose tissue secretes various proteins referred to as adipokines, being involved in inflammation. It was recognized that mesenteric adipose tissue (MAT) is altered by inflammation, and pathologies such as...